Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 50/100

Failure Rate

7.4%

9 terminated/withdrawn out of 122 trials

Success Rate

85.9%

-0.6% vs industry average

Late-Stage Pipeline

20%

24 trials in Phase 3/4

Results Transparency

4%

2 of 55 completed trials have results

Key Signals

5 recruiting2 with results7 terminated

Enrollment Performance

Analytics

N/A
46(51.1%)
Phase 3
14(15.6%)
Phase 2
10(11.1%)
Phase 4
10(11.1%)
Phase 1
9(10.0%)
Early Phase 1
1(1.1%)
90Total
N/A(46)
Phase 3(14)
Phase 2(10)
Phase 4(10)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (122)

Showing 20 of 122 trials
NCT07559591Not ApplicableNot Yet Recruiting

High Flow Tracheal Oxygen for Weaning of Tracheostomized Patients

Role: lead

NCT07429929Not Yet Recruiting

Saudi Emergency Laparotomy Audit

Role: lead

NCT07357506Not ApplicableNot Yet Recruiting

Reducing Skin Side Effects in Patients Receiving Radiation on Tomotherapy

Role: lead

NCT07361029Phase 1Recruiting

CD19 Chimeric Antigen Receptor (CAR) T Cells in Adults With Relapsed/Refractory CD19 Positive Acute Lymphoblastic Leukemia

Role: lead

NCT07324174Not ApplicableNot Yet Recruiting

A Randomized Controlled Trial on the Effectiveness of Early Versus Conservative Rehabilitation Following Rotator Cuff Repair

Role: lead

NCT07318571Not ApplicableRecruiting

AI-Assisted Skin Assessment for Pressure Injury Prevention in Critical Care Nurses

Role: lead

NCT07316777Not Yet Recruiting

Saudi CABG Audit and Registry

Role: lead

NCT07243041Recruiting

Code Status Discussions in Muslim ICU Patients: Insights Into Physician-Family Communication

Role: lead

NCT07172997Active Not Recruiting

Non-Invasive MASLD Diagnosis & T2D Remission Biomarkers

Role: collaborator

NCT07115810Completed

No Prognostic or Molecular Disparity Between Synchronous and Metachronous Metastases in Differentiated Thyroid Cancer: Insight From Middle Eastern Cohort

Role: lead

NCT07068282Phase 1Completed

The Effect of Novel D3 Use as a Mouthwash in COVID-19 Patients

Role: lead

NCT07056088Not ApplicableNot Yet Recruiting

Comparing Blood Glucose Control Intraoperative Between Insulin Drip vs. Insulin Boluses Will Provide Valuable Information on the Optimal Method for Achieving Blood Glucose Control Intraoperatively.

Role: lead

NCT05342350Terminated

International Study of High-Risk Patients for Hepatocellular Carcinoma Using Liquid Biopsy

Role: collaborator

NCT07008040Not ApplicableEnrolling By Invitation

Assessing the Effect of the Silver Dressing on Surgical Site Infections in Adult Patients Post Cardiac Surgery: a Single Center Randomized Control Trial

Role: lead

NCT06993766Not Yet Recruiting

The Predictability of CD19 Expression Across Primitive Cellular Fractions of Relapsed B-ALL on Outcomes of CD19-targeted CAR T-cells

Role: lead

NCT06974344Phase 4Not Yet Recruiting

Octreotide vs. Splenic Artery Ligation for Portal Flow Modulation in Living Donor Liver Transplants (SCALOP Trial)

Role: lead

NCT05818644Enrolling By Invitation

Hepatic Artery Stenosis and Thrombosis After Liver Transplantation in Children

Role: collaborator

NCT05381987Not ApplicableCompleted

The Effectiveness of Radial Shockwave Therapy on Myofascial Pain Syndrome in Neck and Upper Back.

Role: lead

NCT04314219Phase 3Recruiting

Comparing Post-Transplant Cyclophosphamide As GVHD Prophylaxis to Standard of Care for Acute Leukemia Patients

Role: lead

NCT06812676Not ApplicableCompleted

Virtual Reality Induced Analgesia for Nasal Procedures

Role: lead